Addlife Ab Class BOMXSTO: ALIF_B

ALIF_B: EBITA margins exceeded 12% in both segments, with strong growth and a positive M&A outlook

· Issued by Addlife Ab Class B

Margin and profit improvements drove EBITA above 12% in both segments, with 5% revenue growth and strong cash flow. Acquisition of Edge Medical and a robust M&A pipeline position the group for further growth.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Addlife Ab Class B

All Addlife Ab Class B news releases